Home » Topics » BioWorld Science

BioWorld Science
RSS

Sumitomo Dainippon Pharma patents mGlu2 receptor negative allosteric modulators

Nov. 14, 2019

AlaMab Therapeutics discloses connexin-43 antibodies

Nov. 14, 2019

KINE-101, a novel synthetic peptide for rheumatoid arthritis

Nov. 14, 2019

Anti-LAG-3 monoclonal antibodies described by Pharmaexplorer, Shanghai Pharmaexplorer

Nov. 14, 2019

Phase I data reported for FPT-155 in patients with advanced solid tumors

Nov. 14, 2019

MG-1131, a novel anti-TIGIT monoclonal antibody with promising in vitro efficacy

Nov. 14, 2019

Urinary TIMP2 and IGFBP7 as early biomarkers to predict drug induced AKI

Nov. 14, 2019

First-in-human data for ASN-007 presented

Nov. 14, 2019

First patient dosed in phase I/II study of the bicycle toxin conjugate BT-5528

Nov. 14, 2019

Results from multiple phase III studies of anemia treatment roxadustat presented

Nov. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026